 "Sohini Das")
Sohini Das
Sohini Das
Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.
Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.
Page 2 - Sohini Das
US may gain edge in India trade talks over Russian oil purchases: Experts
US senate passes bill threatening 100% tariff on top russian oil buyers
 "US may gain edge in India trade talks over Russian oil purchases: Experts")
Govt weighs incorporating trade-margin rationalisation into DPCO
No deadline set for policy; non-scheduled drugs account for 82% of market, average channel markup on common dosage forms is 43%
 "Govt weighs incorporating trade-margin rationalisation into DPCO")
CGHS dues delayed by up to 18 months, strain private hospital finances
Providers say delayed payments, unexplained claim rejections and below-cost reimbursement for some cancer drugs are straining finances despite recently revised CGHS rates
 "CGHS dues delayed by up to 18 months, strain private hospital finances")
'India began drug discovery before China, but China has moved years ahead'
India's pharma industry must pivot from global leadership in generics to innovation, backed by stronger policy, R&D funding and regulatory reforms, says Satish Reddy
 "'India began drug discovery before China, but China has moved years ahead'")
Molbio eyes overseas growth after OptraScan secures USFDA clearance
Molbio Diagnostics plans to expand its overseas business through subsidiary OptraScan after the latter secured USFDA clearance, while diversifying beyond tuberculosis-focused public-health revenues.
 "Molbio eyes overseas growth after OptraScan secures USFDA clearance")
Audi India targets doubling India luxury-car share in three years
Audi expects sales to remain broadly flat in 2026 before returning to growth in 2027 as the new models begin contributing
 "Audi India targets doubling India luxury-car share in three years")
Anand Mahindra calls Class of 2026 a 'superhero generation' amid AI era
Anand Mahindra says old career templates no longer hold as jobs appear and disappear rapidly
 "Anand Mahindra calls Class of 2026 a 'superhero generation' amid AI era")
Indian drugmakers in no rush to shift to US despite tariff threat
Indian pharma companies are expanding selectively in the US for complex products while retaining India as their manufacturing base despite Trump's tariff threat
 "Indian drugmakers in no rush to shift to US despite tariff threat")
Ramkrishna Forgings expects exports to recover on stronger global orders
The company expects exports to contribute 35 per cent of FY27 revenue as demand improves in North America and Europe, helping absorb newly created manufacturing capacity
 "Ramkrishna Forgings expects exports to recover on stronger global orders")
M&M eSUV biz shifts gear from ₹101 cr loss to ₹288 cr profit in a year
Revenue rises 77% YoY; PBIT margin improves 860 bps as XEV 9S drives volumes, EV penetration
 "M&M eSUV biz shifts gear from ₹101 cr loss to ₹288 cr profit in a year")
M&M Q1 PAT rises 34% to ₹5,455 crore; revenue grows 28% to ₹58,188 cr
Auto and farm profits rise 18%; services PAT jumps 80% on improved performance at MMFSL and Tech Mahindra
 "M&M Q1 PAT rises 34% to ₹5,455 crore; revenue grows 28% to ₹58,188 cr")
Mahindra's EV arm turns unicorn with ₹322 crore funding, IPO on track
Rs 322-crore funding led by Lightrock values Mahindra Last Mile Mobility at Rs 10,822 crore as the company targets a second-half FY27 listing
 "Mahindra's EV arm turns unicorn with ₹322 crore funding, IPO on track")
RPG Life Sciences carves out API arm; InvAscent to invest up to ₹243 crore
Company scouts for USFDA-approved assets; on track for ₹1,000 crore in revenue by FY28
 "RPG Life Sciences carves out API arm; InvAscent to invest up to ₹243 crore")
Regulatory hurdles eclipse tariff worries for pharma CXOs: Deloitte survey
Industry seeks AI-based submission tools and unified digital portals to accelerate approvals and compliance tracking
The reform booster shot that transformed India into pharmacy of the world
From generics to global leadership, India's pharmaceutical industry has transformed since 1991. Its next challenge is becoming a global hub for breakthrough drug innovation
 "The reform booster shot that transformed India into pharmacy of the world")
Fermenta Biotech expands plant-based Vitamin D3 capacity at Dahej plant
Dahej facility to begin commercial production in FY28; company targets nutraceuticals, functional foods and import substitution
Camso, premium push put tyremaker Ceat on growth track; costs cloud FY27
Tyre maker expects premium products, exports and Camso integration to support growth, while higher raw-material costs, freight and geopolitical risks weigh on margins
 "Camso, premium push put tyremaker Ceat on growth track; costs cloud FY27")
Dr Reddy's antibiotic gets Thailand approval six months after US nod
Thailand has become the second country after the US to approve Dr Reddy's first-in-class antibiotic zoliflodacin, a milestone that could accelerate access to the drug across emerging markets
 "Dr Reddy's antibiotic gets Thailand approval six months after US nod")
Electric car race widens as new entrants gain traction in H1 CY26
Maruti, VinFast and Tesla capture 8.1% market, account for 18% of incremental registrations
 "Electric car race widens as new entrants gain traction in H1 CY26")
Maruti targets 25-30% growth in SUV sales in FY27 on new Brezza, launches
SUV contribution to Maruti Suzuki's domestic sales has risen from 12 per cent in FY23 to around 30 per cent in the first quarter of FY27
 "Maruti targets 25-30% growth in SUV sales in FY27 on new Brezza, launches")